Glucotrack Publishes Peer-Reviewed Study Validating Long-Term Accuracy of Continuous Blood Glucose Monitor
Summary
Glucotrack announced the publication of a peer-reviewed study validating the long-term accuracy and stability of its continuous blood glucose monitoring (CBGM) technology, a key milestone for its FDA submission pathway.
Key Events
-
Peer-Reviewed Study Published
Glucotrack announced the publication of a scientific article in The Journal of Diabetes Research, providing external validation for its continuous blood glucose monitoring (CBGM) technology.
-
Strong Preclinical Results
An in-vivo ovine study demonstrated a weighted average Mean Absolute Relative Difference (MARD) of 6.8% over periods of up to 240 days, indicating excellent accuracy and consistent performance, with no device-related adverse safety events.
-
Supports FDA Submission
The positive long-term accuracy and stability data reinforce the company's confidence in the CBGM platform's design and are crucial for advancing towards an Investigational Device Exemption (IDE) submission with the FDA.
Analysis
Glucotrack, a medical technology company, announced the publication of a peer-reviewed study demonstrating the long-term accuracy and stability of its continuous blood glucose monitoring (CBGM) technology. The in-vivo ovine study showed a strong Mean Absolute Relative Difference (MARD) of 6.8% over 240 days with no adverse events. This external validation is a critical step for the company, reinforcing confidence in its platform's design and supporting its progression towards an Investigational Device Exemption (IDE) submission with the FDA. For a micro-cap company like Glucotrack, positive preclinical data is highly significant, as it de-risks the core technology and strengthens the path to commercialization.
At the time of this filing, GCTK was trading at $0.83 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.62 to $15.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.